Holen Sie sich die Stockscreener-App
1.16
2.95%
0.0043
Handel nachbörslich:
1.16
Schlusskurs vom Vortag:
$1.1557
Offen:
$1.17
24-Stunden-Volumen:
60,397
Relative Volume:
2.37
Marktkapitalisierung:
$62.24M
Einnahmen:
$151.37M
Nettoeinkommen (Verlust:
$-36.78M
KGV:
-1.2131
EPS:
-0.9562
Netto-Cashflow:
$25.70M
1W Leistung:
-2.48%
1M Leistung:
-22.24%
6M Leistung:
-48.27%
1J Leistung:
+13.48%
1-Tages-Spanne:
$1.13
$1.22
1-Wochen-Bereich:
$1.12
$1.2202
52-Wochen-Spanne:
$0.88
$3.8799
Zenvia Inc Stock (ZENV) Company Profile
Firmenname
Zenvia Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ZENV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ZENV | 1.16 | 62.24M | 151.37M | -36.78M | 25.70M | -0.9562 |
| CRM | 322.08 | 307.34B | 36.47B | 5.63B | 11.46B | 1.59 |
| SAP | 231.37 | 266.32B | 36.09B | 2.98B | 7.67B | 5.2918 |
| NOW | 1,004.67 | 208.67B | 10.46B | 1.34B | 3.35B | 7.72 |
| INTU | 678.54 | 192.63B | 16.29B | 2.96B | 4.63B | 8.44 |
| UBER | 69.35 | 143.80B | 41.96B | 4.40B | 5.96B | -0.22 |
Zenvia Inc Stock (ZENV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-09-21 | Herabstufung | Itau BBA | Outperform → Market Perform |
| 2021-08-23 | Eingeleitet | Itau BBA | Outperform |
| 2021-08-16 | Eingeleitet | Goldman | Buy |
Zenvia Inc Aktie (ZENV) Neueste Nachrichten
Zenvia Inc(ZENV) Price Target Increased by 5.68% to 1.58 - MSN
Zenvia Inc (ZENV) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Revenues Working Against Zenvia Inc.'s (NASDAQ:ZENV) Share Price Following 26% Dive - Simply Wall St
Zenvia Inc. (NASDAQ:ZENV) Short Interest Update - MarketBeat
ZENVIA sets agenda for fiscal third quarter and first nine months 2024 results - StockTitan
This Zenvia Insider Increased Their Holding By 964% Last Year - Simply Wall St
Zenvia Inc. (NASDAQ:ZENV) Q2 2024 Earnings Call Transcript - MSN
Zenvia CMO Marcelo Wakatsuki steps down, interim named By Investing.com - Investing.com South Africa
Zenvia Inc. Announces Leadership Change in Marketing - TipRanks
Zenvia CMO Marcelo Wakatsuki steps down, interim named - Investing.com UK
Zenvia establishes at-the-market equity programme in Brazil - Latin Lawyer
Zenvia Customer Cloud hits the market with AI to revolutionize Brand-CX - Martechcube
Zenvia Customer Cloud hits the market with AI to revolutionize Brand-Customer experiences - StockTitan
Zenvia Inc. (NASDAQ:ZENV) Short Interest Up 24.6% in September - MarketBeat
Zenvia Inc. (NASDAQ:ZENV) Short Interest Down 59.9% in September - MarketBeat
Affinity Asset Advisors LLC Invests $3.84 Million in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Canada
Is this affordable and accessible eyewear brand worth the hype? - Reviewed
Wedbush lifts Zentalis Pharmaceuticals Inc [ZNTL] price estimate. Who else is bullish? - The DBT News
Trading Day Review: Zevra Therapeutics Inc (ZVRA) Loses Momentum, Closing at 7.53 - The Dwinnex
Adversity is less terrifying than hope: Zentalis Pharmaceuticals Inc (ZNTL) - SETE News
You might want to take a look at Zevra Therapeutics Inc (ZVRA) now - SETE News
Potential Price Increase for Zentalis Pharmaceuticals Inc (ZNTL) After Recent Insider Activity - Knox Daily
Daily Market Movement: Zentalis Pharmaceuticals Inc (ZNTL) Sees a 11.41 Increase, Closing at 4.10 - The Dwinnex
Zenith UK appoints Sannah Rogers chief executive - CampaignLive
Zendaya's baby pics that show she's always been that girl - Hindustan Times
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com Canada
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor - Pharmaceutical Technology
Zevra Therapeutics Inc (ZVRA)’s stock decline to 7.78 per share - US Post News
Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies - Zacks Investment Research
Zeneara Reviews"HYPE-LEGIT" HAPPY Customer or Controversy? - openPR
IPO Radar: Applied Nutrition, Zenas BioPharma, BingEx - The Armchair Trader
Zenith Bank Rises Slightly after ‘Fund’ Amass Huge Shares - MarketForces Africa
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock By Investing.com - Investing.com South Africa
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com
Understanding the Risks of Investing in Zevra Therapeutics Inc (ZVRA) - Knox Daily
Zentalis Pharmaceuticals Inc’s Banking’s 100-Day Moving Average at 6.58: Will the Stock Break Through? - The InvestChronicle
Zentalis clinical hold resolution came ‘no strings attached,’ says Oppenheimer - TipRanks
Zentalis Pharma gains as FDA lifts partial clinical hold on cancer drug studies - XM
Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies - MarketWatch
Zentalis Pharmaceuticals Advances with FDA Approval and Upcoming Data - TipRanks
Zenas Biopharma IPO raises $225 mln in US IPO market - Eyes On News
Zenas BioPharma shares rise nearly 8% in market debut - XM
Zenas BioPharma raises $225 mln in US IPO - Reuters
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering - GlobeNewswire
Zenvia Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion By Investing.com - Investing.com Canada
Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion - Investing.com India
Finanzdaten der Zenvia Inc-Aktie (ZENV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.57%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):